1. "Clifford Hudis"
  2. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (14)
Groups
  1. Breast Medicine Service (30)
  2. Department of Medicine (30)
  3. Molecular Imaging and Therapy Service (30)
  4. Radiology, Department of (30)
  5. Solid Tumor Oncology Division (30)
  6. Survivorship Research (30)

More Groups

People
  1. Clifford Hudis (30)
  2. Shanu Modi (17)
  3. Maxine Jochelson (16)
  4. Gary Ulaner (13)
  5. Steven Larson (13)
  6. Patrick Morris (12)

More People

Years
  1. 2020 (1)
  2. 2019 (4)
  3. 2018 (1)
  4. 2017 (3)
  5. 2016 (2)
  6. 2015 (6)

More Years

Publications
  1. Cancer Research (7)
  2. Journal of Clinical Oncology (6)
  3. Annals of Oncology (2)
  4. Biomaterials (1)
  5. Breast Cancer Research and Treatment (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (6)
  3. Oxford University Press (3)
  4. Springer (2)
  5. Wiley Blackwell (2)
  6. Academic Press, Elsevier Inc (1)

More Publishers

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human trial of epichaperome-targeted PET in patients with cancer
    Journal Article

    Dunphy, M. P. S.; Pressl, C.; Pillarsetty, N.; Grkovski, M.; Modi, S.; Jhaveri, K.; Norton, L.; Beattie, B. J.; Zanzonico, P. B.; Zatorska, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • Copper-64 trastuzumab PET imaging: A reproducibility study
    Journal Article

    Carrasquillo, J. A.; Morris, P. G.; Humm, J. L.; Smith-Jones, P. M.; Beylergil, V.; Akhurst, T.; O'Donoghue, J. A.; Ruan, S.; Modi, S.; Hudis, C. A.; more...
    Quarterly Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS)
    Journal Article

    He, F.; Springer, N. L.; Whitman, M. A.; Pathi, S. P.; Lee, Y.; Mohanan, S.; Marcott, S.; Chiou, A. E.; Blank, B. S.; Iyengar, N.; more...
    Biomaterials (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomas
    Journal Article

    Kunitake, J. A. M. R.; Choi, S.; Nguyen, K. X.; Lee, M. M.; He, F.; Sudilovsky, D.; Morris, P. G.; Jochelson, M. S.; Hudis, C. A.; Muller, D. A.; more...
    Journal of Structural Biology (2018)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save